# Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor - Optimize Trial

Study · id `cardio:ct-nct01113372` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01113372](<https://clinicaltrials.gov/study/NCT01113372>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01113372

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 3119 participants.

## Technical summary

Registry record NCT01113372. Randomized; single masking; primary purpose supportive care. Start 2010-04 (registry gives no type); primary completion 2013-02 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose supportive care
- Phase: Phase 4
- Enrolled: 3119 participants (enrolled count; ClinicalTrials.gov record NCT01113372, source copy `cardio:ctgov-nct01113372-2015-12-18`, retrieved 2026-10-26)
- Start date: 2010-04 (registry gives no type) (ClinicalTrials.gov record NCT01113372, source copy `cardio:ctgov-nct01113372-2015-12-18`, retrieved 2026-10-26)
- Primary completion: 2013-02 (actual) (ClinicalTrials.gov record NCT01113372, source copy `cardio:ctgov-nct01113372-2015-12-18`, retrieved 2026-10-26)
- Completion: 2015-07 (actual) (ClinicalTrials.gov record NCT01113372, source copy `cardio:ctgov-nct01113372-2015-12-18`, retrieved 2026-10-26)
- Countries: Brazil (ClinicalTrials.gov record NCT01113372, source copy `cardio:ctgov-nct01113372-2015-12-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01113372-2015-12-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor - Optimize Trial
- Acronym: OPTIMIZE
- Condition: Coronary Artery Disease
- Intervention (Drug): Clopidogrel
- Lead sponsor: Cardiovascular Research Center, Brazil
- Lead sponsor class: OTHER
- Collaborator: Medtronic
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry intervention name matches this record: Clopidogrel (`cardio:clopidogrel`)
- Registry intervention is a member of this class by a sourced record link: P2Y12 inhibitors (drug class) (`cardio:p2y12-inhibitors`)
- Registry lists this organization as a collaborator: Medtronic (`cardio:medtronic`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial (`cardio:pubmed-24177257`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: a46fdf7b4f261c2e1b23eeb0a13593402153ca60f5d7e08515a3e947396d68a4
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
